Helios Energy has pinpointed a high-potential unconventional sweet spot alongside multiple conventional oil and gas targets within its Presidio Project, setting the stage for near-term drilling and potential value re-rating.
Neurotech International reports encouraging Phase I human pharmacokinetic results for its pediatric cannabinoid drug NTI164, alongside published clinical trial data in Rett Syndrome and key regulatory progress in the US and Australia.
